Patient treatment pathway analysis for venom allergies

  • Increased customer/patient satisfaction and conversion rate

  • Gained a better understanding of stakeholders’ and patients’ behaviour along the pathway

  • Compiled key parameters to focus on when launching products to mitigate venom allergies


CLIENT REQUIREMENTS
  • Understand the patient treatment pathway for allergic reactions to bee/wasp/hornet stings
  • Understand a patient’s experience with healthcare providers during treatment of allergy
  • Understand a patient’s preference for and experience with venom immunotherapy (VIT)
OUR APPROACH
  • Conducted detailed primary research of c.300 patients diagnosed with allergies to bee/wasp/hornet stings
    • Respondent selection: respondents from six European countries diagnosed medically with venom allergies
    • Diagnosis and treatment: in-depth analysis of diagnosis of allergic reactions and treatment modalities
    • Experience with VIT: information on familiarity with VIT treatment, adoption and completion of treatment
  • Analysed the large amount of data the research generated to gain meaningful insight on a patient’s behaviour
    • Demographic analysis: analysed patient preferences and behaviour by demographic and geography Stakeholder
    • Stakeholder analysis: analysed the level of interaction between patients and stakeholders at different stages of treatment and assessed the importance of each stakeholder
    • VIT treatment analysis: analysed a patient’s preference for VIT over other treatment and studied how they were made aware of such treatment
VALUE DELIVERED
  • Acuity Knowledge Partners provided research and analysis support to formulate actionable insights
  • Provided a comprehensive assessment of demographics, stakeholders and patient behaviour
  • Highlighted the importance of each parameter along the VIT treatment pathway
  • Identified level of penetration and stakeholders’ knowledge of current treatments
  • Helped client ascertain which stakeholders or regions to target and focus resources on
  • Highlighted patients’ pain points along the treatment pathway, helping the client improve their product/s and service
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on

What we have done

Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Competitor benchmarking and performance gap analysis for a leading European medical device player
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Assessing viability of entering the NSCLC market
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Assessment of GCC pharmaceutical market for a global European pharma major
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Product launch strategy for European biopharmaceutical company
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Research on a multiple sclerosis drug with help from global neurologists
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach

Procurement in non-Food FMCG Industry
What we are proud of

>50%

savings in staffing costs

25%

increase in outreach